Book Closure

BAL PHARMA LTD.

NSE : BALPHARMABSE : 524824ISIN CODE : INE083D01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE98.25-2.63 (-2.61 %)
PREV CLOSE ( ) 100.88
OPEN PRICE ( ) 100.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12167
TODAY'S LOW / HIGH ( )96.95 102.00
52 WK LOW / HIGH ( )71 132.2
NSE98.30-2.3 (-2.29 %)
PREV CLOSE( ) 100.60
OPEN PRICE ( ) 100.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 98.30 (123)
VOLUME 22289
TODAY'S LOW / HIGH( ) 97.10 101.75
52 WK LOW / HIGH ( )77.5 132.45

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.